Effectiveness of COVID-19 Vaccines Over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population
31 Pages Posted: 20 Sep 2022
Yiyi Xu
University of Gothenburg - Department of Public Health and Community Medicine
Huiqi Li
University of Gothenburg - Department of Public Health and Community Medicine
Brian Kirui
University of Gothenburg - Department of Public Health and Community Medicine
Ailiana Santosa
University of Gothenburg - Department of Public Health and Community Medicine
Magnus Gisslen
University of Gothenburg - Department of Infectious Diseases
Susannah Leach
University of Gothenburg - Department of Microbiology and Immunology
Bjorn Wettermark
Uppsala University - Department of Pharmacoepidemiology & Social Pharmacy
Lowie E.G.W. Vanfleteren
Sahlgrenska University Hospital - COPD Center
Fredrik Nyberg
University of Gothenburg - Department of Public Health and Community Medicine
and severe outcomes [hospitalization (b), ICU admission (c), death (d)] after two doses.
Legend: VE denotes vaccine effectiveness. Area within dotted line indicates 95% confidence
intervals. Red line indicate VE=0.
VE after two doses before and after the emergence of the Omicron
The more fast-waning VE that we observed for the entire follow-up than in other earlier
published data appeared likely to be related to the emergence of Omicron. Therefore, the
analyses for the pre-Omicron and Omicron periods separately are particularly important.
There was a large difference in VE against infection before and after the emergence of
Omicron. Before Omicron, VE was above 85% for most time intervals (Figure 3a, Table S8),
whereas VE was lower and decreased quickly for infection caused by Omicron and two doses
of vaccine showed no protection against infection by week 14 (Figure 3b, Table S8).
A difference in VE from pre-Omicron and Omicron period was also observed for
hospitalization, but it was not as large as for infection (Figure 3c and 3d, Table S9). Before
Omicron, VE was stable, durable, and high (above 85%), while VE against hospitalization
caused by Omicron was about 80% up to week 25 and then decreased but showed some
protection against hospitalization during the entire follow-up
4 件のコメント:
国土の逆向きチンコですねw
スウェーデンの人口1035万人(2020)だそうですが、国民の9割に使用しないとワクチンの効果の全容が分かりませんwとか、医者その他科学に携わる皆さん
頭 大 丈 夫 で す か ?
今 ま で の 人 生 何 し て た ん で す か ?
惰 眠 を 貪 っ て た ん で す か ?
wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww
wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww
百聞は一見に如かず。科学に携わっていることになっていた皆さんの程度の低さが可視化されたんですね。
もう無駄でしょうし諦めが肝心です 勇者はうつしかないでしょ
コメントを投稿